Trends and predictions of perioperative transfusion and venous thromboembolism in hepatectomy using a North American Registry
Monica Ha, Kenneth E. Stewart, Amir L. Butt, Kofi B. Vandyck, Sydany Tran, Ajay Jain, Barish Edil, Kenichi A. Tanaka- Hematology
- Immunology
- Immunology and Allergy
Abstract
Background
Studies indicate a link between allogeneic blood transfusion and venous thromboembolism (VTE) post‐major surgery. Analyzing trends and predictors of these outcomes after hepatectomy can inform risk management.
Methods
The American College of Surgeons National Surgical Quality Improvement Program database was used for a retrospective analysis. Primary outcomes were perioperative red blood cell (RBC) transfusion and VTE events within 30 days of hepatectomy. Seven‐year trends and predictors were evaluated.
Results
Among 29,131 hepatectomy patients, transfusion rates showed no statistically significant decreasing trends (p = .122) from 2014 to 2020 (18.13%–16.71%), while VTE rates showed a downward trend over the 7 years (p = .021); 17.2% received RBC transfusion, with higher rates in surgeries lasting ≥282 min (median: 220 min). Calculated RBC mass [hematocrit (%) × body weight (kg) × 10−5 × 70/(body mass index/22)] at or below 1.5 L substantially increased transfusion odds. VTE was reported postoperatively in 2.6% of cases more frequently in longer cases involving transfusions. The adjusted odds ratio (aOR) of VTE escalated from the shortest operative time to the longest (3.17; 95% confidence interval [CI], 2.37–4.22). The adjusted odds of VTE doubled for transfused patients compared to non‐transfused patients (aOR, 2.19; 95% CI, 1.86–2.57).
Conclusions
Rates of RBC transfusion and VTE rates hepatectomy have minimally changed in the recent years. VTE prevention is challenging in extended surgeries at increased risk of bleeding and RBC transfusions. Patient‐level data on coagulation and thromboprophylaxis can potentially refine risk assessment for postoperative VTE.